AI and AR Revolutionize Dementia Care
AI and AR technologies offer innovative solutions for dementia care, aiding patients and reducing caregiver burden.
- Latest
- Trending
AI and AR technologies offer innovative solutions for dementia care, aiding patients and reducing caregiver burden.
Nexalin shares are 1% shorted; 52-week range $0.25-$3.40. Market cap: $6.69M, PE ratio: -1.36, beta: 5.13. Qtr EPS: -$0.10; ROE: ...
Cambridge researchers have discovered that virtual reality (VR) may be able to detect early symptoms of Alzheimer's disease by testing ...
According to a new study, a majority of retired individuals in 17 US retirement communities enjoyed using virtual reality (VR) ...
A groundbreaking study by Stanford University reveals how virtual reality technology is improving the emotional well-being and social interactions of ...
Tech companies are addressing the loneliness epidemic caused by technology's isolation. Groove, Rendever, and Luka are using innovative approaches to ...
Virtual reality experiences are revolutionizing aged care by allowing residents to explore the world from the comfort of their homes. ...
Virtual Reality is revolutionizing patient care in the medical field by improving surgical outcomes, enhancing patient consultations, and offering novel ...
Japanese stocks surged as the Nikkei reached a 34-year high due to strong corporate earnings and a surge in tech-related ...
Otsuka's phase 3 trial for AVP-786 in treating agitation in Alzheimer's patients has failed to meet the primary efficacy endpoint. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.